Endothelin-1 in Subarachnoid Hemorrhage
Author(s) -
Klaus Faßbender,
Britta Hodapp,
S. Rossol,
Thomas Bertsch,
Joachim Schmeck,
Sandra Schütt,
Michael Fritzinger,
Peter A. Horn,
Peter Vajkoczy,
Martina Wendel-Wellner,
Andreas Ragoschke,
Sandra Kuehl,
Jürgen Brunner,
L. Schürer,
Peter Schmiedeck,
Michael G. Hennerici
Publication year - 2000
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/01.str.31.12.2971
Subject(s) - medicine , subarachnoid hemorrhage , endothelin receptor , endothelin 1 , vasospasm , cerebrospinal fluid , peripheral blood mononuclear cell , tumor necrosis factor alpha , ischemia , inflammation , cerebral vasospasm , cytokine , immunology , pathology , in vitro , receptor , biology , biochemistry
The most potent vasoconstrictor known, endothelin-1, is currently considered to mediate cerebral vasospasm in subarachnoid hemorrhage (SAH), which can cause delayed cerebral ischemia. In our study, we performed clinical and in vitro experiments to investigate the origin and the mechanisms of the secretion of endothelin-1 in SAH.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom